Literature DB >> 9819132

DNA typing for natural killer cell inhibiting HLA-Cw groups NK1 and NK2 by PCR-SSP.

C Frohn1, P Schlenke, B Ebel, C Dannenberg, G Bein, H Kirchner.   

Abstract

Over the last few years, natural killer (NK) cells have been shown to express MHC molecule recognizing receptors which are thought to function primarily as negative signaling receptors. HLA-Cw seems to play a key role as the corresponding ligand. Two distinct HLA-Cw groups which differ in amino acid residues 77 and 80 inhibit separate subsets of NK cells. In order to classify target cells with respect to their expression of HLA-Cw groups we established a group specific PCR-SSP which directly amplifies the relevant epitope coding sequences. The PCR protocol was validated by retyping cell lines obtained from the International Histocompatibility Workshop and by comparing those results with those acquired from allele-specific genotyping and serotyping on 80 donor-recipient pairs from our kidney transplantation unit. In the context of inhibitory HLA-Cw receptors, our protocol which definitively discriminates the two alternative epitopes is the more direct and thus more reliable approach, and is less labor intensive compared to an allele specific PCR or serotyping. In addition serotyping does not detect at all certain alleles. Basic NK cell research and clinical transplantation immunology may benefit from this newly established PCR SSP technique.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819132     DOI: 10.1016/s0022-1759(98)00126-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.

Authors:  Hojjatollah Nozad Charoudeh; Laurent Schmied; Asensio Gonzalez; Grzegorz Terszowski; Karol Czaja; Karin Schmitter; Laura Infanti; Andreas Buser; Martin Stern
Journal:  Immunogenetics       Date:  2012-07-07       Impact factor: 2.846

2.  NK cell development in a human stem cell niche: KIR expression occurs independently of the presence of HLA class I ligands.

Authors:  Xiaoyi Zhao; Sandra Weinhold; Jens Brands; Maryam Hejazi; Özer Degistirici; Gesine Kögler; Roland Meisel; Markus Uhrberg
Journal:  Blood Adv       Date:  2018-10-09

3.  KIR : HLA association with clinical manifestations of HBV infection in Madurai, south India.

Authors:  Narayanan Kalyanaraman; Lakshmikanthan Thayumanavan; Mariakuttikan Jayalakshmi
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

4.  Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.

Authors:  Karina L McQueen; Kristel M Dorighi; Lisbeth A Guethlein; Ruby Wong; Bharati Sanjanwala; Peter Parham
Journal:  Hum Immunol       Date:  2007-03-12       Impact factor: 2.850

5.  Does the KIR2DS5 gene protect from some human diseases?

Authors:  Izabela Nowak; Edyta Majorczyk; Andrzej Wiśniewski; Andrzej Pawlik; Maria Magott-Procelewska; Ewa Passowicz-Muszyńska; Jacek Malejczyk; Rafał Płoski; Sebastian Giebel; Ewa Barcz; Aleksandra Zoń-Giebel; Andrzej Malinowski; Henryk Tchórzewski; Arkadiusz Chlebicki; Wioleta Łuszczek; Maciej Kurpisz; Marian Gryboś; Jacek Wilczyński; Piotr Wiland; David Senitzer; Ji-Yao Sun; Renata Jankowska; Marian Klinger; Piotr Kuśnierczyk
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

6.  Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody.

Authors:  Manish Suneja; Sarat Kuppachi
Journal:  Clin Kidney J       Date:  2012-04-19

7.  Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment.

Authors:  Edyta Majorczyk; Andrzej Pawlik; Daria Gendosz; Piotr Kuśnierczyk
Journal:  BMC Musculoskelet Disord       Date:  2014-07-28       Impact factor: 2.362

8.  KIR2DS5 in the presence of HLA-C C2 protects against endometriosis.

Authors:  Izabela Nowak; Rafał Płoski; Ewa Barcz; Piotr Dziunycz; Paweł Kamiński; Grażyna Kostrzewa; Łukasz Milewski; Piotr I Roszkowski; David Senitzer; Jacek Malejczyk; Piotr Kuśnierczyk
Journal:  Immunogenetics       Date:  2015-03-01       Impact factor: 2.846

9.  Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.

Authors:  Astrid Tschan-Plessl; Martin Stern; Laurent Schmied; Christelle Retière; Hans H Hirsch; Christian Garzoni; Christian van Delden; Katia Boggian; Nicolas J Mueller; Christoph Berger; Jean Villard; Oriol Manuel; Pascal Meylan; Grzegorz Terszowski
Journal:  Transplant Direct       Date:  2016-06-17

10.  KIR and HLA-C genes in male infertility.

Authors:  Karolina Wilczyńska; Paweł Radwan; Rafał Krasiński; Michał Radwan; Jacek R Wilczyński; Andrzej Malinowski; Ewa Barcz; Izabela Nowak
Journal:  J Assist Reprod Genet       Date:  2020-05-20       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.